Home » Topics » BioWorld Science

BioWorld Science
RSS

Nanogen Recognomics created from Nanogen-Aventis R&T collaboration

July 19, 2001

BTG commences phase I clinical trial of new anticancer agent

July 19, 2001

Synthetic low-molecular-weight thrombin inhibitor and oral prodrug profiled at ISTH meeting

July 19, 2001

Novartis discovers potential new class of antidiabetic agents

July 19, 2001

Discovery of novel classes of CFTR activators revealed by U. of California team

July 19, 2001

Major European launch for single-bolus thrombolytic

July 19, 2001

Positive phase II results for NBI-34060 in subjects with chronic insomnia

July 19, 2001

New pseudomycin prodrugs with superior therapeutic index

July 19, 2001

PTC Therapeutics awarded SBIR grant to support HIV research

July 19, 2001

Corixa and Nycomed Amersham Imaging to copromote Metastron

July 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...